866-997-4948(US-Canada Toll Free)

Oropharyngeal Cancer - Pipeline Review, H1 2013

Published By :

Global Markets Direct

Published Date : Apr 2013

Category :

Cancer

No. of Pages : 38 Pages


Global Markets Direct’s, \'Oropharyngeal Cancer - Pipeline Review, H2 2013\', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Oropharyngeal Cancer. 

Oropharyngeal Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • A snapshot of the global therapeutic scenario for Oropharyngeal Cancer.
  • A review of the Oropharyngeal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Oropharyngeal Cancer pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Oropharyngeal Cancer.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Oropharyngeal Cancer pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Table of Contents

Introduction
Global Markets Direct Report Coverage
Oropharyngeal Cancer Overview
Therapeutics Development
An Overview of Pipeline Products for Oropharyngeal Cancer
Oropharyngeal Cancer Therapeutics under Development by Companies
Oropharyngeal Cancer Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Oropharyngeal Cancer Therapeutics – Products under Development by Companies
Oropharyngeal Cancer Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Oropharyngeal Cancer Therapeutics Development
The University of Texas M. D. Anderson Cancer Center
Advaxis, Inc.
Oropharyngeal Cancer – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ADXS-HPV - Drug Profile
Product Description
Mechanism of Action
R&D Progress
bevacizumab + [carboplatin] + [cisplatin] + [docetaxel] + [fluorouracil] - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ketorolac tromethamine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Alpha GalactosylCeramide Pulsed Dendritic Cells - Drug Profile
Product Description
Mechanism of Action
R&D Progress
minocycline - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Oropharyngeal Cancer Therapeutics – Drug Profile Updates
Oropharyngeal Cancer Therapeutics – Discontinued Products
Oropharyngeal Cancer Therapeutics - Dormant Products

Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Table


Number of Products Under Development for Oropharyngeal Cancer, H1 2013
Products under Development for Oropharyngeal Cancer – Comparative Analysis, H1 2013
Number of Products under Development by Companies, H1 2013
Number of Products under Investigation by Universities/Institutes, H1 2013
Comparative Analysis by Late Stage Development, H1 2013
Comparative Analysis by Mid Clinical Stage Development, H1 2013
Comparative Analysis by Early Clinical Stage Development, H1 2013
Products under Development by Companies, H1 2013
Products under Investigation by Universities/Institutes, H1 2013
The University of Texas M. D. Anderson Cancer Center, H1 2013
Advaxis, Inc., H1 2013
Assessment by Monotherapy Products, H1 2013
Assessment by Combination Products, H1 2013
Assessment by Stage and Route of Administration, H1 2013
Assessment by Stage and Molecule Type, H1 2013
Oropharyngeal Cancer Therapeutics – Drug Profile Updates
Oropharyngeal Cancer Therapeutics – Discontinued Products
Oropharyngeal Cancer Therapeutics – Dormant Products

List of Chart


Number of Products under Development for Oropharyngeal Cancer, H1 2013
Products under Development for Oropharyngeal Cancer – Comparative Analysis, H1 2013
Products under Development by Companies, H1 2013
Products under Investigation by Universities/Institutes, H1 2013
Late Stage Products, H1 2013
Mid Clinical Stage Products, H1 2013
Early Clinical Stage Products, H1 2013
Assessment by Monotherapy Products, H1 2013
Assessment by Combination Products, H1 2013
Assessment by Route of Administration, H1 2013
Assessment by Stage and Route of Administration, H1 2013
Assessment by Molecule Type, H1 2013
Assessment by Stage and Molecule Type, H1 2013

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *